Efficacy Rates
- All
- News
-
Covaxin 77.8% Effective Against Covid, Says Lancet Study
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against symptomatic COVID-19 in a long-awaited analysis published in The Lancet.
-
Covaxin Found To Be 77.8% Effective Against Covid In Lancet Study
Covaxin, a vaccine developed by government's medical research agency and Bharat Biotech International Ltd., was found to have a 77.8% efficacy rate against symptomatic Covid-19 in a long-awaited analysis published in The Lancet.
-
Covid Vaccine From Germany's CureVac Just 48% Effective
Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna.
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
RBI Keeps Key Rates Unchanged, Says Recovery "Uncertainty" Due To Covid
Reserve Bank of India Governor Shaktikanta Das has kept the key rates unchanged, saying the recent resurgence in Covid-19 infections has created "uncertainty" about recovery in economic growth. The central bank retained the repo rate at 4 per cent and the reverse repo rate at 3.35 per cent. The RBI Governor said that vaccine distribution and its ef...
-
Weekly Insulin Helps Patients With Type 2 Diabetes Achieve Similar Results To Daily Insulin
Diabetes: According to a study, a new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin.
-
China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism
Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks.
-
India Inc. Hails Moody's Upgrade; Some Feel Fitch, S&P May Not Follow
Sunil Bharti Mittal, founder and chairman, Bharti Enterprises, said that the upgrade "underlines the efficacy of the bold structural reforms".
-
Duvvuri Subbarao Questions Inflation-Targeting, Doubts Its Efficacy
Former Reserve Bank governor Duvvuri Subbarao has doubted achieving the 4 per cent inflation target set under the new MPC set-up given the narrow margin the new price index has now and the way prices have been moving up in recent months.
-
BRICS Moves to Establish Bank Institute, Rating Agency
BRICS countries on Friday discussed the efficacy of "establishing" a bank institute and a rating agency of their own following the New Development Bank (NDB) becoming fully operational.
-
How a communication gap made the rupee crisis worse
The rupee has fallen 10 per cent since July 15, when the Reserve Banks announced its first major plan to defend the currency. These steps to tighten liquidity sent overnight interest rates higher. But even as analysts were discussing the efficacy of these measures, RBI Governor D Subbarao said the RBI may withdraw these cash tightening steps in a c...
-
Covaxin 77.8% Effective Against Covid, Says Lancet Study
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against symptomatic COVID-19 in a long-awaited analysis published in The Lancet.
-
Covaxin Found To Be 77.8% Effective Against Covid In Lancet Study
Covaxin, a vaccine developed by government's medical research agency and Bharat Biotech International Ltd., was found to have a 77.8% efficacy rate against symptomatic Covid-19 in a long-awaited analysis published in The Lancet.
-
Covid Vaccine From Germany's CureVac Just 48% Effective
Germany's CureVac announced Wednesday that final trial results showed its coronavirus vaccine had an efficacy rate of just 48 percent, far lower than those developed by mRNA rivals BioNTech and Moderna.
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
-
RBI Keeps Key Rates Unchanged, Says Recovery "Uncertainty" Due To Covid
Reserve Bank of India Governor Shaktikanta Das has kept the key rates unchanged, saying the recent resurgence in Covid-19 infections has created "uncertainty" about recovery in economic growth. The central bank retained the repo rate at 4 per cent and the reverse repo rate at 3.35 per cent. The RBI Governor said that vaccine distribution and its ef...
-
Weekly Insulin Helps Patients With Type 2 Diabetes Achieve Similar Results To Daily Insulin
Diabetes: According to a study, a new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin.
-
China Covid Shot Has 4 Wildly Different Efficacy Rates, Fuels Skepticism
Days before a global rollout kicks off with the President of Indonesia receiving the Sinovac Biotech Ltd. vaccine on live television, uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks.
-
India Inc. Hails Moody's Upgrade; Some Feel Fitch, S&P May Not Follow
Sunil Bharti Mittal, founder and chairman, Bharti Enterprises, said that the upgrade "underlines the efficacy of the bold structural reforms".
-
Duvvuri Subbarao Questions Inflation-Targeting, Doubts Its Efficacy
Former Reserve Bank governor Duvvuri Subbarao has doubted achieving the 4 per cent inflation target set under the new MPC set-up given the narrow margin the new price index has now and the way prices have been moving up in recent months.
-
BRICS Moves to Establish Bank Institute, Rating Agency
BRICS countries on Friday discussed the efficacy of "establishing" a bank institute and a rating agency of their own following the New Development Bank (NDB) becoming fully operational.
-
How a communication gap made the rupee crisis worse
The rupee has fallen 10 per cent since July 15, when the Reserve Banks announced its first major plan to defend the currency. These steps to tighten liquidity sent overnight interest rates higher. But even as analysts were discussing the efficacy of these measures, RBI Governor D Subbarao said the RBI may withdraw these cash tightening steps in a c...
